Cell therapy in Sjögren's syndrome: opportunities and challenges
Expert Reviews in Molecular Medicine · 2024 · 26
DOI: 10.1017/erm.2024.21 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Reviews in Molecular Medicine, online erschienen am 23.10.2024. Verfasst von Yangyang Lu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China. Hauptthemen laut MEDLINE: Sjogren's Syndrome, Cell- and Tissue-Based Therapy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Science Foundation of Shanxi Health Commission.
Abstract (Originalsprache)
Sjögren's syndrome (SS) is a chronic autoimmune disease caused by immune system disorders. The main clinical manifestations of SS are dry mouth and eyes caused by the destruction of exocrine glands, such as the salivary and lacrimal glands, and systemic manifestations, such as interstitial pneumonia, interstitial nephritis and vasculitis. The pathogenesis of this condition is complex. However, this has not been fully elucidated. Treatment mainly consists of glucocorticoids, disease-modifying antirheumatic drugs and biological agents, which can only control inflammation but not repair the tissue. Therefore, identifying methods to regulate immune disorders and repair damaged tissues is imperative. Cell therapy involves the transplantation of autologous or allogeneic normal or bioengineered cells into the body of a patient to replace damaged cells or achieve a stronger immunomodulatory capacity to cure diseases, mainly including stem cell therapy and immune cell therapy. Cell therapy can reduce inflammation, relieve symptoms and promote tissue repair and regeneration of exocrine glands such as the salivary glands. It has broad application prospects and may become a new treatment strategy for patients with SS. However, there are various challenges in cell preparation, culture, storage and transportation. This article reviews the research status and prospects of cell therapies for SS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Third Hospital of Shanxi Medical University, Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Tongji Shanxi Hospital, Taiyuan, China.
- Shanxi Province Clinical Research Center for Dermatologic and Immunologic Diseases (Rheumatic diseases), Taiyuan, China.
- Shanxi Province Clinical Theranostics Technology Innovation Center for Immunologic and Rheumatic Diseases, Taiyuan, China.
- Shanxi Academy of Advanced Research and Innovation, Taiyuan, China.
ORCID-Profile: Yangyang Lu, Dan Ma
Förderung
- China Postdoctoral Science Foundation
- Science Foundation of Shanxi Health Commission
Zitieren
APA
Lu, Y., Shi, R., He, W., An, Q., Zhao, J., Gao, X., Zhang, B., Zhang, L., Xu, K., & Ma, D. (2024). Cell therapy in Sjögren's syndrome: opportunities and challenges. Expert Reviews in Molecular Medicine, 26. https://doi.org/10.1017/erm.2024.21
Vancouver
Lu Y, Shi R, He W, An Q, Zhao J, Gao X, et al. Cell therapy in Sjögren's syndrome: opportunities and challenges. Expert Reviews in Molecular Medicine. 2024;26. doi:10.1017/erm.2024.21
BibTeX
@article{Lu2024,
author = {Lu, Yangyang and Shi, Rongjing and He, Wenqin and An, Qi and Zhao, Jingwen and Gao, Xinnan and Zhang, Baiyan and Zhang, Liyun and Xu, Ke and Ma, Dan},
title = {Cell therapy in Sjögren's syndrome: opportunities and challenges},
journal = {Expert Reviews in Molecular Medicine},
year = {2024},
volume = {26},
doi = {10.1017/erm.2024.21}
}
EUVIMED